EICHORCondition: Tricuspid Valve Regurgitation · Sponsor: Abbott Medical Devices
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The bRIGHT EU PAS study is an observational real-world study evaluating severe tricuspid regurgitation patients treated with the Abbott TriClip™ device (bRIGHT EU Post-Approval Study).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: 1. Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy. 2. Subjects eligible to receive the TriClip™ per the current approved Indications for Use. 3. Subject must provide written informed consent prior to study procedure. Exclusion Criteria: 1\. Subjects participating in another clinical study that may impact the follow-up or results of this study.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Universitätsklinik Graz | Graz, Austria | — |
| Odense University Hospital | Odense, Denmark | — |
| University Hospital Bonn | Bonn, North Rhine-Westphalia, Germany | — |
| Universitatsmedizin der Johannes Gutenberg-Universitat Mainz | Mainz, Rhineland-Palatinate, Germany | — |
| Leipzig Heart Center | Leipzig, Saxony, Germany | — |
| Zentralklinik Bad Berka GmbH | Bad Berka, Germany | — |
| Herz-und Diabetes Zentrum NRW | Bad Oeynhausen, Germany | — |
| Schüchtermann-Schiller´sche Kliniken GmbH & Co. KG | Bad Rothenfelde, Germany | — |
| DRK Kliniken Köpenick | Berlin, Germany | — |
| St.-Johannes-Hospital | Dortmund, Germany | — |
| Elisabeth-Krankenhaus Essen GmbH | Essen, Germany | — |
| Katholisches Marienkrankenhaus GmbH | Hamburg, Germany | — |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04483089